权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Identification of the Exposome in Fatty Liver Disease in Mexican American Families Using Genetic Correction

使用基因校正鉴定墨西哥裔美国人家庭脂肪肝中的暴露组

基本信息

批准号：
10307087
负责人：
John Blangero
金额：
$ 72.61万
依托单位：
UNIVERSITY OF TEXAS RIO GRANDE VALLEY
依托单位国家：
美国
项目类别：
财政年份：
2018
资助国家：
美国
起止时间：
2018-04-27 至 2024-11-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10307087
关键词：
20 year old Address Adult Affect Age Alcohol consumption Alcoholic Fatty Liver Behavior Behavioral Biological Biological Factors Biological Markers Characteristics Chemicals Chronic Cirrhosis Data Development Disease Environment Environmental Exposure Environmental Risk Factor Ethnic Origin Etiology Exhibits Exposure to Family Family Study Fatty Liver Fatty acid glycerol esters Fibrinogen Fibrosis Genetic Genetic Variation Genotype Gills Hepatitis Viruses Heritability High Prevalence Hispanic Populations Human Individual Infectious Agent Insulin Resistance Lead Life Life Style Lipids Liver Liver Cirrhosis Liver Failure Liver Fibrosis Liver diseases Magnetic Resonance Imaging Measurement Measures Mexican Americans Minority Groups Nature Non-Insulin-Dependent Diabetes Mellitus Nutrient Obesity Participant Persons Pharmaceutical Preparations Pharmacologic Substance Phenotype Physical activity Plasma Population Predisposing Factor Prevalence Preventive measure Preventive treatment Primary carcinoma of the liver cells Public Health Reporting Research Project Grants Risk Risk Factors Role Signal Transduction Site Socioeconomic Factors South Texas Spatial Distribution Speed Steatohepatitis Technology Time Toxin Transaminases base chronic liver disease clinically relevant cohort design dietary disorder risk epigenomics ethnic minority population fatty liver disease genetic approach genetic pedigree genome sequencing genome wide methylation health disparity populations high dimensionality improved lipidomics liver imaging liver inflammation liver injury mRNA sequencing medically underserved member metabolomics microbiome non-alcoholic fatty liver disease non-genetic novel novel strategies pollutant recruit response sex transcriptome transcriptomics whole genome

项目摘要

PROJECT SUMMARY Fatty liver disease (FLD) is a major public health issue affecting millions of people worldwide. Chronic FLD is defined by excess liver fat (hepatic steatosis) and can lead to a more profound disease state of steatohepatitis (SH) that may be reflected in hepatic fibrosis (including severe cirrhosis at the extreme). SH can lead to liver failure or hepatocellular carcinoma (HCC). Multiple risk factors predispose individuals to the development of FLD including biological factors (obesity, insulin resistance, type 2 diabetes) demographic characteristics (e.g. sex, age and ethnicity), behavioral and lifestyle-related variables (e.g., alcohol intake, dietary behavior and physical activity), and both endogenous (e.g., infectious agents such as hepatitis viruses, microbiome variability) and exogenous environmental factors (e.g., exposure to pollutants/contaminants/toxins). Mexican Americans are disparately impacted by nonalcoholic FLD with some of the highest observed prevalences in the world and exhibit a prevalence of cirrhosis that is 9 times the national average. Although there is a heritable component of FLD risk, the dramatic increase FLD and HCC prevalence over the past 20 years clearly points to a major role for environmental factors since genetic variation is effectively constant on such a timescale. In this project, we will use high-dimensional omic characterization of Mexican Americans living in South Texas to assess the FLD-relevant environmentally determined exposome. We will recruit 1,000 participants from the longitudinal San Antonio Mexican American Family Study (SAMAFS) to undergo magnetic resonance imaging (MRI) to obtain measures of liver fat and liver fibrosis. Each participant has previously been completely genetically characterized by whole genome sequencing, and the WGS data will be employed to optimally identify the exposome for FLD risk in a minority population. To achieve these objectives, we will: (I) perform MRI-based measures of liver fat/fibrosis and omic characterization of 1,0000 individuals from large extended SAMAFS pedigrees, including metabolomic profiling, lipidomic profiling, epigenomic analysis, and transcriptomic sequencing; (II) detect environmental effects on FLD risk using a novel statistical genetic approach to maximize systematic environmental signals and search for environmental factors reflected in high-dimensional metabolomic/lipidomic, epigenomic, and transcriptomic biomarkers that are correlated with FLD risk; (III) characterize/classify environmental signals with regard to major environmental domains through the identification of non-random spatial distribution, or correlation with known components such as dietary behavior, socioeconomic factors, exogenous exposures, etc.; (IV) detect genotype x environment interactions using the omic data to detect genetic factors involved in the differential response of FLD risk to novel environmental factors. Overall, the ability to identify novel environmental determinants of chronic liver disease risk in an ethnic minority population provides a major opportunity to speed the development of improved targeted treatments.

项目摘要脂肪肝（FLD）是影响全球数百万人的主要公共卫生问题。慢性FLD是定义为肝脏脂肪过多（肝脂肪变性），并可导致更严重的脂肪性肝炎疾病状态 (SH)这可能反映在肝纤维化（包括极端的严重肝硬化）。SH可导致肝脏失败或肝细胞癌（HCC）。多种危险因素使个体易患FLD 包括生物学因素（肥胖、胰岛素抵抗、2型糖尿病）人口统计学特征（例如性别，年龄和种族），行为和生活方式相关的变量（例如，酒精摄入、饮食行为和身体状况活性），和内源性（例如，感染因子，如肝炎病毒、微生物组变异性），外部环境因素（例如，接触污染物/污染物/毒素）。墨西哥裔美国人受非酒精性FLD的严重影响，在世界上观察到的患病率最高，肝硬化患病率是全国平均水平的9倍尽管FLD有遗传因素在过去的20年里，FLD和HCC患病率的急剧增加清楚地表明，环境因素，因为遗传变异在这样的时间尺度上实际上是恒定的。在这个项目中，我们将使用高维度的组学表征墨西哥裔美国人生活在南德克萨斯州评估FLD相关的环境决定性问题。我们将从纵向圣安东尼奥墨西哥裔美国人家庭研究（SAMAFS）进行磁共振成像 (MRI)以获得肝脂肪和肝纤维化的测量值。每个参与者之前都已经完全通过全基因组测序进行遗传特征分析，WGS数据将用于最佳识别在少数人群中存在FLD风险的麻烦。为了实现这些目标，我们将：（一）进行基于MRI的来自大型扩展SAMAFS的1，0000名个体的肝脏脂肪/纤维化和组学特征的测量谱系，包括代谢组学分析、脂质组学分析、表观基因组学分析和转录组学分析。测序;（II）使用新的统计遗传方法检测环境对FLD风险的影响，以最大化系统的环境信号和搜索环境因素反映在高维与FLD风险相关的代谢组学/脂质组学、表观基因组学和转录组学生物标志物;（III）对环境信号进行表征/分类，非随机空间分布的识别，或与已知成分如饮食行为的相关性，社会经济因素、外源性暴露等; (IV)检测基因型x环境的相互作用，使用组学数据，以检测参与FLD风险对新环境因素的差异反应的遗传因素。总体而言，识别少数民族慢性肝病风险的新环境决定因素的能力人口普查为加速改进靶向治疗的发展提供了一个重要机会。